The scientist’s investigation covers issues in Cancer research, Apoptosis, Cell biology, Protein kinase B and Kinase. His Cancer research study combines topics in areas such as Jurkat cells, XIAP, Histone deacetylase inhibitor, Sodium butyrate and Leukemia. Steven Grant has researched Apoptosis in several fields, including Molecular biology, Endocrinology and Myeloid leukemia.
His Cell biology research includes elements of Cell cycle and Downregulation and upregulation. His Protein kinase B research incorporates themes from Radiosensitivity, PI3K/AKT/mTOR pathway, Cell killing and Bcl-2-associated X protein. He combines subjects such as Autophagy, Unfolded protein response, Endoplasmic reticulum and Ceramide with his study of Programmed cell death.
Steven Grant mostly deals with Cancer research, Apoptosis, Cell biology, Programmed cell death and Molecular biology. His work deals with themes such as Protein kinase B, Leukemia, Immunology, Vorinostat and Kinase, which intersect with Cancer research. His Apoptosis research is multidisciplinary, incorporating perspectives in Cell culture, Downregulation and upregulation and Bortezomib.
His Cell biology research integrates issues from Autophagy and Caspase. Many of his studies involve connections with topics such as Ceramide and Programmed cell death. His Molecular biology research incorporates elements of Biochemistry, Transfection and Cytotoxicity.
His primary areas of study are Cancer research, Bortezomib, Apoptosis, Pharmacology and Protein kinase B. His Cancer research research is multidisciplinary, relying on both Vorinostat, Histone deacetylase and Leukemia, Immunology. His research on Bortezomib also deals with topics like
Programmed cell death and Autophagy are the primary areas of interest in his Apoptosis study. His work carried out in the field of Pharmacology brings together such families of science as Fas receptor, FADD, Chemotherapy and In vivo. Steven Grant works mostly in the field of Protein kinase B, limiting it down to concerns involving PI3K/AKT/mTOR pathway and, occasionally, Regorafenib and Kinase.
His main research concerns Cancer research, Apoptosis, Molecular biology, Gene knockdown and Protein kinase B. His research integrates issues of Leukemia, Immunology, PI3K/AKT/mTOR pathway and Programmed cell death in his study of Cancer research. Steven Grant interconnects Downregulation and upregulation and Cell biology in the investigation of issues within Apoptosis.
His Molecular biology study combines topics from a wide range of disciplines, such as Unfolded protein response, Transfection and OSU-03012. His Protein kinase B research includes themes of Sphingosine, Cell growth and MAPK/ERK pathway. The study incorporates disciplines such as Small hairpin RNA and Computational biology in addition to Autophagy.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin.
Autophagy (2016)
Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356
Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin.
Autophagy (2016)
MAPK pathways in radiation responses
Paul Dent;Adly Yacoub;Paul B Fisher;Michael P Hagan.
Oncogene (2003)
Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway.
W D Jarvis;R N Kolesnick;F A Fornari;R S Traylor.
Proceedings of the National Academy of Sciences of the United States of America (1994)
Stress and radiation-induced activation of multiple intracellular signaling pathways.
Paul Dent;Adly Yacoub;Joseph Contessa;Ruben Caron.
Radiation Research (2003)
Induction of Apoptotic DNA Fragmentation and Cell Death in HL-60 Human Promyelocytic Leukemia Cells by Pharmacological Inhibitors of Protein Kinase C
Jarvis Wd;Turner Aj;Povirk Lf;Traylor Rs.
Cancer Research (1994)
Mcl-1 down-regulation potentiates ABT-737 lethality by cooperatively inducing Bak activation and Bax translocation.
Shuang Chen;Yun Dai;Hisashi Harada;Paul Dent.
Cancer Research (2007)
Induction of apoptosis in U937 human leukemia cells by suberoylanilide hydroxamic acid (SAHA) proceeds through pathways that are regulated by Bcl-2/Bcl-XL, c-Jun, and p21CIP1, but independent of p53.
J A Vrana;R H Decker;C R Johnson;Z Wang.
Oncogene (1999)
Radiation-induced cell signaling: inside-out and outside-in
Kristoffer Valerie;Adly Yacoub;Michael P. Hagan;David T. Curiel.
Molecular Cancer Therapeutics (2007)
Apoptosis Induced by the Kinase Inhibitor BAY 43-9006 in Human Leukemia Cells Involves Down-regulation of Mcl-1 through Inhibition of Translation
Mohamed Rahmani;Eric Maynard Davis;Cheryl Bauer;Paul Dent.
Journal of Biological Chemistry (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Virginia Commonwealth University
Virginia Commonwealth University
Virginia Commonwealth University
Washington University in St. Louis
Yale University
Virginia Commonwealth University
Virginia Commonwealth University
Virginia Commonwealth University
University of Rochester
The University of Texas MD Anderson Cancer Center
University of Bologna
City University of New York
University of Queensland
University of Surrey
Spanish National Research Council
Harvard University
Case Western Reserve University
Duke University
Leibniz Association
The University of Texas System
United States Geological Survey
University of Duisburg-Essen
Children's Hospital of Philadelphia
Saint Mary's University
University of Southern California
The Open University